Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Survival Prediction in Gliomas: Current State and Novel Approaches

In: Gliomas [Internet]. Brisbane (AU): Exon Publications; 2021 Apr 30. Chapter 9.
Affiliations
Review

Survival Prediction in Gliomas: Current State and Novel Approaches

Rachel Zhao et al.

Excerpt

Gliomas are neurologically devastating tumors with generally poor outcomes. Traditionally, survival prediction in glioma is studied from clinical features using statistical approaches. With the rapid development of artificial intelligence approaches encompassing machine learning and deep learning, there has been a keen interest among researchers to apply these methods to survival prediction in glioma allowing for integrated processes that encompass pathology, histology, molecular, imaging, and clinical features. This chapter provides an overview of the emerging computational approaches that have the potential to revolutionize survival prediction in glioma. Machine learning and deep learning techniques, including support vector machine, random forest, convolutional neural network, and radiomics, are discussed.

PubMed Disclaimer

References

    1. Wee CW, Kim IH, Park CK, Kim JW, Dho YS, Ohka F, et al. Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study. Radiother Oncol. 2018;129(2):347–51. https://doi.org/10.1016/j.radonc.2018.09.001. - DOI - PubMed
    1. Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, et al. Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. JAMA Oncol. 2017;3(6):784–92. - PMC - PubMed
    1. Curran WJ, Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993;85(9):704–10. https://doi.org/10.1093/jnci/85.9.704. - DOI - PubMed
    1. Li J, Wang M, Won M, Coughlin C, Curran WJ, Mehta MP, et al. Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys. 2011;81(3):623–30. https://doi.org/10.1016/j.ijrobp.2010.06.012. - DOI - PMC - PubMed
    1. Zanello M, Roux A, Ursu R, Peeters S, Bauchet L, Noel G, et al. On the Behalf of the Club de Neuro-Oncologie of the Société Française de Neurochirurgie Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment? J Neurooncol. 2017;135(2):285–97. https://doi.org/10.1007/s11060-017-2573-y. - DOI - PubMed